Bill Ackman is a self-described ‘Buffett devotee’—and wants his $28 billion Pershing empire to be the ‘modern-day’ Berkshire

Pershing Square filed to list on the NYSE aiming to raise $5–$10 billion via a dual listing (closed-end fund ticker PSUS and parent PS), down from a failed $25 billion attempt in 2024; the deal includes 20 free parent shares per 100 closed-fund shares and a $5,000 minimum order. The move is designed to secure 'permanent capital' to emulate Berkshire Hathaway's long-term capital model; Pershing manages ~$28 billion AUM and recently paid $900 million for a controlling stake in Howard Hughes Holdings, which is now the subject of a shareholder lawsuit alleging an unfair price.

Analysis

A high-profile activist converting part of their franchise into permanent capital materially changes the supply-demand dynamics for control stakes and private asset takeovers. Permanent capital reduces forced selling risk and raises the value of illiquid, high-conviction positions; over a 3–5 year horizon this can compress required IRR thresholds for large take-private bids, enabling bigger control deals at lower entry multiples than peer managers constrained by redemptions.

Market microstructure will create immediate arbitrage and volatility opportunities: parent/closed-end cross-holdings and any introductory incentives create a convertible-like ratio that can be mispriced versus modeled NAV. Closed-end vehicles also carry a long-runized discount tail (histor average ~10–15% depending on distribution policy); capturing or hedging that gap requires active monitoring of spreads, lockups and secondary sell pressure in the first 30–180 days post-listing.

Tail risks center on execution and governance: litigation around control transactions or activist governance missteps can turn permanent capital into a source of leverage rather than protection, with concentrated reputational drawdowns that can take 6–24 months to resolve. The contrarian read is that the market may overpay for the narrative of ‘permanent capital + celebrity manager’ while underweighting conglomerate-style execution risk and the reality of a persistent conglomerate discount unless underlying ROICs consistently exceed cost of capital.

Key Decisions for Investors

• Structure a ratio arb around the new parent/closed-end pairing at listing: if implied conversion-adjusted spread >2% vs modeled NAV, buy the cheaper leg and short the richer leg size-limited to 1–2% AUM. Time horizon: 0–90 days to capture initial re-rating; stop-loss 4% adverse move in the spread to limit corporate-action risk.
• Buy protection on Howard Hughes (HHH) — initiate HHH 9–12 month put options or a modest short equity position (target 30–60% downside if litigation/governance outcome is adverse). Position size: small (0.5–1% AUM) given binary event risk; max loss = premium or equity size.
• If the new permanent-capital vehicle prices at a meaningful discount to modeled NAV (>=8%) enter a buy on weakness with a 12–36 month hold targeting NAV convergence + manager alpha; hedge with short exposure to short-duration active managers ETF or specific hedge funds if available to compress style risk. Risk/reward: aim for 15–30% total return vs 100% downside limited to cost basis—use trailing stop at 12% drawdown.
• Take a defensive overweight in BRK.B as a valuation/strategy hedge versus execution risk in the activist’s conglomerate path. Timeframe: tactical 6–24 months during potential consolidation of activist’s holdings; expected hedge benefit is correlation reduction rather than direct alpha — size 1–2% AUM.